Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancers

BACKGROUND: Tumor mesothelin overexpression is present in different malignancies, including the majority of patients with pancreatic or biliary cancers. The objective of this study was to evaluate the use of shed serum mesothelin and megakaryocyte potentiating factor (MPF) concentrations as biomarke...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Chem Lab Med
Asıl Yazarlar: Sharon, Elad, Zhang, Jingli, Hollevoet, Kevin, Steinberg, Seth M., Pastan, Ira, Onda, Masanori, Gaedcke, Jochen, Ghadimi, B. Michael, Ried, Thomas, Hassan, Raffit
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6309905/
https://ncbi.nlm.nih.gov/pubmed/22149739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/CCLM.2011.816
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller